First Patient Dosed in Phase 1 Clinical Trial of KB407 for the Treatment of Cystic Fibrosis
PITTSBURGH, July 03, 2023. Krystal Biotech, Inc. (the“Company”), a biotechnology company focused on developing and commercializing genetic medicines for patients with debilitating diseases, announced today that the first patient has... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - July 3, 2023 Category: Pharmaceuticals Source Type: clinical trials

Sweat Response, Sweat Composition and Thermoregulatory Response to Exercise in Heat in Adults With Cystic Fibrosis on Modulator Therapy.
Condition:   Cystic Fibrosis Intervention:   Sponsors:   University of Portsmouth;   University Hospital Southampton NHS Foundation Trust Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 9, 2023 Category: Research Source Type: clinical trials